Bottom line, up front: Botox and Xeomin are both botulinum toxin type A injectables. Xeomin is the “naked” toxin because it has been stripped of the complexing (accessory) proteins that surround Botox’s active molecule. Onset and longevity are similar (3 to 4 months). Unit-for-unit dosing is roughly 1:1 between the two. The clinical reason to pick Xeomin is most often patients with suspected antibody resistance to Botox or those who want a formulation without the accessory protein load.
When patients hear about Xeomin for the first time, the question is almost always: is it just a cheaper Botox? The short answer is no — they are siblings in the same neurotoxin family, but the formulations differ in a way that matters for a specific subset of patients. This guide walks through what that “naked toxin” label actually means, how the two products perform in clinical practice, and how to decide which one belongs in your treatment plan.
For broader category context, see our neurotoxins guide. If you are also weighing other options, our Botox vs Dysport breakdown and the new Botox vs Daxxify comparison round out the four major brands.
What is Xeomin and what makes it the “naked toxin”?
Xeomin (incobotulinumtoxinA) is an FDA-approved botulinum toxin type A injectable from Merz Aesthetics. It received FDA approval for cosmetic glabellar lines in 2011 and is also approved for several therapeutic uses including cervical dystonia, blepharospasm, and chronic sialorrhea.
The “naked” or “pure” nickname comes from how the molecule is processed. The active part of any botulinum toxin product is the 150-kilodalton neurotoxin protein itself. In manufacturing, that neurotoxin is naturally surrounded by larger accessory or “complexing” proteins — hemagglutinins and a non-toxic non-hemagglutinin. Botox and Dysport leave those complexing proteins in the final product. Xeomin uses a proprietary purification step to remove them, leaving only the active 150-kDa neurotoxin protein in the vial. That stripped-down formulation is the “naked toxin” branding.
How does Xeomin work in the body?
The mechanism is identical to Botox. Both products block acetylcholine release at the neuromuscular junction. The muscle relaxes, the overlying skin stops creasing, and dynamic wrinkles smooth. With repeat treatments, the muscle becomes less reflexively active and the surface skin gets a chance to remodel.
The proposed clinical advantage of removing the complexing proteins is reduced antigenic load. The complexing proteins do not contribute to the neurotoxin’s muscle-relaxing effect, and in theory, fewer non-active proteins per injection means a lower long-term chance of the body forming neutralizing antibodies. Whether this translates into a meaningful real-world difference for cosmetic patients is still debated — most cosmetic users do not get treated frequently enough or at high enough doses for antibody formation to become clinically relevant. Patients receiving high-dose therapeutic Botox (for spasticity or cervical dystonia, often 200 to 400 units per visit) are the population where antibody resistance is best documented.
Botox vs Xeomin at a glance
How long does Xeomin last compared with Botox?
Real-world duration is similar. Pivotal trials of Xeomin for glabellar lines reported median duration of effect in the same 3-to-4-month window seen with Botox. Direct head-to-head comparative studies (NEUVANTAGE program from Merz) found non-inferiority for Xeomin against Botox for glabellar lines.
Individual variation exists. A patient who has a very expressive face, exercises intensely, or has a higher resting metabolic rate may notice movement returning at 10 to 12 weeks rather than 14. That pattern is independent of which toxin was used — it reflects the patient’s biology more than the product.
Who is Xeomin a better fit for?
The strongest case for Xeomin
- Suspected antibody resistance to Botox. Patients who report progressively shorter duration over many years, especially after high-dose therapeutic use, may have developed neutralizing antibodies. Switching to the “naked toxin” can sometimes restore response.
- Long-term cosmetic users on yearly retreatment for 10+ years. The lower antigenic load is the strongest theoretical argument, even if real-world data in cosmetic patients is limited.
- Patients who want a formulation without HSA (rare). Xeomin still contains HSA, but the rest of the formulation is leaner than Botox’s by virtue of having no complexing proteins. (Xeomin does still use human serum albumin and sucrose.)
- Patients who are price-sensitive in markets where Xeomin runs slightly lower. In some Orange County markets, Xeomin per-unit pricing is $1 to $2 lower than Botox. That is not a guarantee — pricing is highly injector-dependent.
When Botox is still the better default
- First-time neurotoxin patients with no prior product history.
- Patients with one of Botox’s medical insurance-covered indications (chronic migraine, hyperhidrosis, cervical dystonia) where switching could complicate cross-product approval.
- Patients who have responded well to Botox for years and have no reason to change.
What does the research show?
The pivotal evidence for Xeomin in cosmetic glabellar lines comes from a series of Phase 3 randomized trials sponsored by Merz, including the GL-1 trial program that established efficacy and safety equivalent to placebo at 30 days with a 20-unit dose. Non-inferiority versus Botox for glabellar lines was demonstrated in the NEUVANTAGE program and subsequent head-to-head comparisons (Xeomin FDA prescribing information).
The antibody-formation argument has its strongest evidence in therapeutic use. Long-term studies in cervical dystonia patients show lower rates of neutralizing antibody formation with incobotulinumtoxinA compared to historical onabotulinumtoxinA cohorts. That literature is suggestive but does not directly prove the same advantage in low-dose cosmetic patients, where antibody-mediated failure is uncommon to begin with. Honest framing: Xeomin’s “lower immunogenicity” claim has real biological plausibility and some therapeutic-dose evidence behind it, but is not a settled benefit at cosmetic doses.
What does Xeomin cost?
In Orange County in 2026, Xeomin typically runs $10 to $14 per unit, putting glabellar treatment at $200 to $280 per session for a standard 20-unit dose. Botox in the same market is generally $12 to $16 per unit. The per-unit gap is small and varies more by injector experience and clinic overhead than by the product itself. Manufacturer rewards programs (Aspire by Galderma covers Dysport and Restylane, Allē by Allergan covers Botox and Juvederm, Merz Xperience covers Xeomin and Radiesse) often shift the actual out-of-pocket cost more than the per-unit price does.
What are the side effects?
Xeomin’s side-effect profile mirrors Botox. The common reactions:
- Headache for 24 to 48 hours after treatment
- Mild injection-site bruising or swelling
- Brow heaviness or eyelid ptosis if the toxin is placed too low — typically transient
- Asymmetry that resolves with a small touch-up dose
Serious adverse events (distant spread, allergic reaction) are uncommon for both products. The FDA boxed warning about distant spread applies to all botulinum toxin products. Patients with myasthenia gravis or Lambert-Eaton syndrome should avoid both Xeomin and Botox without specialist supervision.
Can you switch from Botox to Xeomin?
Yes, and the switch is often seamless. Because the unit equivalence is approximately 1:1, your existing Botox dose is generally a reasonable starting point with Xeomin. Most injectors will keep dose constant for the first switch session and adjust based on response at the 2-week follow-up. There is no medical washout requirement; you can switch at your next regularly scheduled visit.
Patients who switch specifically because they suspect antibody resistance should wait at least 12 weeks from their last Botox dose before retesting with Xeomin. That window gives you a cleaner read on how the new product is performing on its own.
Botox vs Xeomin for specific cosmetic areas
- Glabellar (the “11 lines”): FDA approved for both. Either product works at 20 units. See our Botox for forehead lines guide for the full anatomy breakdown.
- Forehead horizontal lines: Off-label for both. Both perform similarly at 8 to 12 units depending on muscle strength.
- Crow’s feet: Off-label for Xeomin (Botox has FDA approval for this area). Real-world performance is comparable.
- Masseter (jaw slimming): Off-label for both. Both are used; injector preference and unit-pricing usually drive the choice.
- Hyperhidrosis (excessive sweating): FDA approved for Botox; off-label for Xeomin. Most insurance-coverage pathways favor Botox here.
How to choose: a simple decision tree
- Have you used Botox before and noticed your results lasting progressively less, even with the same dose? → Talk to your injector about trying Xeomin.
- Are you brand new to neurotoxins and have no clinical reason to prefer one over the other? → Botox or Xeomin both reasonable; injector preference usually wins.
- Do you need neurotoxin treatment for a medical indication (migraine, hyperhidrosis, cervical dystonia)? → Botox has broader insurance-covered indications.
- Are you bothered by the idea of injecting accessory proteins you don’t need? → Xeomin is the formulation argument.
- Is your priority specifically longer duration of effect? → Neither product is the right answer; consider Daxxify.
FAQ
Is Xeomin cheaper than Botox?
Sometimes, slightly. Xeomin per-unit pricing in Orange County is often $1 to $2 lower than Botox, but the difference varies by clinic and rewards program. For a standard 20-unit glabellar treatment, the total cost gap is usually $20 to $40 — not a primary reason to choose between the two.
Does Xeomin really last longer than Botox?
In published trials, median duration of effect is comparable — typically 3 to 4 months for both at glabellar doses. Some patients report a slight edge for one or the other based on personal experience, but neither product is clinically established as longer-lasting at standard cosmetic doses. For meaningful longevity gains, the right comparison is Botox vs Daxxify.
What is unit equivalence between Botox and Xeomin?
Approximately 1:1. Twenty units of Botox is generally interchangeable with twenty units of Xeomin for the same treatment area. This is different from Dysport, where the convention is roughly 2.5 to 3 units of Dysport for every 1 unit of Botox.
Can I become resistant to Xeomin like Botox?
The theoretical antibody-formation risk is lower with Xeomin because the complexing proteins have been removed, leaving less non-active protein to provoke an immune response. In therapeutic-dose populations, lower rates of neutralizing antibody formation have been reported for Xeomin. In cosmetic patients, true antibody resistance is uncommon and the comparative data is more limited.
Will my injector use the same technique for both products?
Yes. Injection technique, marking, and placement are identical between Botox and Xeomin. Reconstitution math is the same. From the patient’s chair, the appointment looks indistinguishable.
If Xeomin doesn’t need refrigeration, does that make it less potent?
No. Room-temperature stability before reconstitution is a formulation property, not a potency issue. Once reconstituted with saline, both products are used within hours and held under similar conditions in the practice.
Is Xeomin FDA approved for everything Botox is approved for?
No. Xeomin is FDA approved for glabellar lines, cervical dystonia, blepharospasm, upper limb spasticity, and chronic sialorrhea. Botox has broader approvals including chronic migraine, hyperhidrosis, overactive bladder, and crow’s feet. For off-label cosmetic use, both products are widely used by experienced injectors.
How to get started
The product matters less than the injector. A skilled injector working with either Botox or Xeomin will deliver a better result than a less-experienced injector working with the “right” product. If you have a specific reason to consider Xeomin — suspected antibody resistance, long history with Botox, formulation preference — bring it up in your consultation directly. If you do not have a specific reason, the choice is largely interchangeable for most cosmetic glabellar treatment.
Medically reviewed by the clinical team at OC Weight Loss and Medspa. Last updated: May 13, 2026.
Talk to a clinician at OC Weight Loss and Medspa
Our injectors carry Botox, Dysport, Daxxify, and Xeomin so we can match the product to the patient, not the other way around. Visit our Botox service page for pricing and to book a consultation.
Book a free consultation
Book a Free Consultation